BioNexus Gene Lab Corp. (BGLC)
1.19
0.00 (0.00%)
USD |
NASDAQ |
Oct 23, 16:00
1.16
-0.03
(-2.52%)
After-Hours: 20:00
BioNexus Gene Lab Profit Margin (Quarterly) : -376.0% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -376.0% |
| March 31, 2026 | -2.38K% |
| December 31, 2025 | -214.2% |
| September 30, 2025 | -27.87% |
| June 30, 2025 | -27.26% |
| March 31, 2025 | -29.17% |
| December 31, 2024 | -13.80% |
| September 30, 2024 | -51.15% |
| June 30, 2024 | 10.08% |
| March 31, 2024 | -4.36% |
| December 31, 2023 | 13.57% |
| September 30, 2023 | -102.2% |
| June 30, 2023 | -10.10% |
| March 31, 2023 | -2.91% |
| December 31, 2022 | -5.53% |
| September 30, 2022 | -3.01% |
| June 30, 2022 | -5.58% |
| Date | Value |
|---|---|
| March 31, 2022 | 0.56% |
| December 31, 2021 | 2.75% |
| September 30, 2021 | 8.26% |
| June 30, 2021 | 0.92% |
| March 31, 2021 | 9.82% |
| December 31, 2020 | 11.17% |
| September 30, 2020 | 7.59% |
| June 30, 2020 | -3.24% |
| March 31, 2020 | 34.84% |
| December 31, 2019 | -174.7% |
| September 30, 2019 | -90.91% |
| June 30, 2019 | -325.9% |
| March 31, 2019 | -218.9% |
| December 31, 2018 | -670.2% |
| September 30, 2018 | -97.16% |
| December 31, 2017 | -101.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intertek Group Plc | -- |
| ALS Ltd. | -- |
| NEXT-ChemX Corp. | -- |
| Capital A Bhd. | 3.11% |
| AECOM | -2.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -33.16% |
| Return on Assets | -22.90% |
| Return on Invested Capital | -32.35% |
| Gross Profit Margin (Quarterly) | 17.06% |
| Operating Margin (Quarterly) | -409.4% |
| Return on Net Operating Assets | -62.22% |